China continues industry probe

Share this article:

China's scrutiny of the drug industry continues. The Wall Street Journal reports that Roche announced government authorities from China's State Administration for Industry and Commerce, an agency which oversees marketing and antitrust, visited a site in Hangzhou.

Thursday's news follows last week's announcement that the Ministry of Public Security accused GlaxoSmithKline of bribing HCPs to stimulate prescriptions.

AstraZeneca, Sanofi and Bayer have also come under review over the last year.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.